
XORTX Therapeutics prices $1.1M (U.S.) direct offering
XORTX Therapeutics prices $1.1M (U.S.) direct offering

XORTX Therapeutics prices $1.1M (U.S.) direct offering
Rocket Doctor AI adds U.S. insurer partners
Briacell adds three sites to Bria-IMT phase 3 study
Cardiol closes $11.4-million (U.S.) financing
Briacell, MSK to work on Bria-OTS+ clinical development
Tempramed arranges $2.5-million private placement
Satellos's SAT-3247 follow-up study doses first patient
Bionxt begins BNT23001 animal bioequivalence study
Amino Innovations Develops Next-Generation Peptide Patch Platform to Redefine Everyday Wellness
Artificial Intelligence Opportunities are Sky Rocketing as Global AI In Healthcare Market is Projected to Reach $504 Billion by 2032
XORTX Announces Pricing of US$1.1 Million Registered Direct Offering
Rocket Doctor Expands U.S. Coverage, Becoming In-Network with Two Leading National Insurers With More Than 6.5 Million Additional Members Across California and New York State
BriaCell Adds Key Clinical Sites in Phase 3 Metastatic Breast Cancer Study
BriaCell Announces Collaboration with MSK Accelerator to Advance Bria-OTS+(TM) for Breast Cancer
Cardiol Therapeutics Completes US$11.4 Million Financing and Extends Cash Runway into Q3 2027